- Abbr. Title:
- ISAR J Med Pharm Sci
- ISSN(Online):
- 2584-0150
- Publisher:
- ISAR Publisher
- Chief Editor:
- Dr. Shivendra Agarwal
- Country of origin:
- India
- Language:
- English
- Frequency:
- Monthly
- Format:
- Online
- Journal starting year:
- 2023
Ethics & Policies
Ethical Guidelines
At ISAR Publisher, we are committed to upholding the highest standards of ethics in publishing. Authors, reviewers, and editors are expected to adhere to the following ethical guidelines:
1. Authors’ Responsibilities
- Originality and Plagiarism: Authors must ensure that their submitted work is original and free from plagiarism. Any use of the work and/or words of others must be appropriately cited.
- Data Integrity: Authors should present accurate data and results. Fabrication, falsification, or selective reporting of data is strictly prohibited.
- Multiple Submissions: Manuscripts must not be submitted to more than one journal simultaneously. Duplicate submissions are considered unethical.
- Authorship: Only individuals who have significantly contributed to the research and writing should be listed as authors. All co-authors must approve the final version of the paper.
- Conflicts of Interest: Authors must disclose any financial or personal relationships that could influence their work.
2. Reviewers’ Responsibilities
- Confidentiality: Manuscripts under review must be treated as confidential documents and not shared or discussed with others.
- Objectivity: Reviews should be conducted objectively, with constructive feedback provided to improve the manuscript.
- Conflict of Interest: Reviewers should decline to review manuscripts where they have conflicts of interest arising from competitive, collaborative, or other relationships with any of the authors or institutions.
- Timeliness: Reviewers are expected to complete their reviews within the specified timeframe.
3. Editors’ Responsibilities
- Fairness: Editors must evaluate manuscripts based solely on academic merit, without regard to the authors’ race, gender, religious belief, ethnic origin, citizenship, or political philosophy.
- Confidentiality: Editors must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, and publisher.
- Decision-Making: Editors are responsible for deciding which articles will be published, based on the reviewers’ evaluations and the journal’s editorial policy.
- Addressing Misconduct: Editors must take responsive measures when ethical complaints are presented concerning a submitted or published manuscript.
4. Ethical Oversight
ISAR Publisher is committed to investigating all allegations of ethical misconduct. We follow COPE (Committee on Publication Ethics) guidelines when handling such issues, ensuring that appropriate action is taken, which may include retraction or correction of the published work.
Policies
Peer Review Policy
All manuscripts submitted to ISAR Journals undergo a rigorous double-blind peer-review process. Reviewers evaluate the quality, significance, and originality of the work, providing valuable feedback to authors.
Open Access Policy
ISAR Publisher is committed to open access publishing to ensure that research is freely accessible to the global community. Authors retain copyright, and articles are published under a Creative Commons Attribution-NonCommercial 4.0 International License.
Data Sharing and Reproducibility
Authors are encouraged to share data and code associated with their manuscripts to facilitate transparency and reproducibility. ISAR Publisher supports the FAIR (Findable, Accessible, Interoperable, Reusable) principles.
Plagiarism Detection
To maintain the integrity of published work, ISAR Publisher employs plagiarism detection tools. Any suspected cases of plagiarism will be thoroughly investigated, and appropriate actions will be taken.
Corrections and Retractions
ISAR Publisher follows COPE (Committee on Publication Ethics) guidelines for corrections and retractions. Corrections are made for minor errors, while retractions are issued for serious ethical violations or major inaccuracies.
Editorial Independence
The editorial team maintains independence from external influences, ensuring fair and unbiased decision-making in all aspects of the journal's operations.
Contact Us
For any questions or concerns related to ethics and policies, please contact our editorial team at [contact@isarpublisher.com].
Background: Tuberculosis (TB) treatment initiation is a critical transition in the care cascade, yet subnational geographic and temporal patterns may be obscured by aggregated estimates. This study characterized patterns of documented TB treatment initiation in Lampung Province, Indonesia.
Methods: We conducted a retrospective observational study using routine TB surveillance data from January to December 2025. All patients residing in Lampung Province with documented treatment initiation were included. Demographic characteristics and monthly and district/city distributions were described. Geographic and temporal variation in treatment initiation counts across 15 districts/cities was assessed using negative binomial regression, with adjusted count ratios (CRs) and 95% confidence intervals (CIs).
Results: Among 20,314 patients, the median age was 46 years (IQR 26–60), 60.5% were male, and 33.7% were aged 45–64 years. Treatment initiations varied substantially geographically, with the highest proportion recorded in Bandar Lampung (15.9%), followed by Lampung Selatan (13.5%) and Lampung Tengah (11.6%). Geographic variation remained significant after adjustment for calendar month (p<0.001). Compared with Bandar Lampung, adjusted treatment initiation counts were lowest in Pesisir Barat (CR 0.11; 95% CI 0.09–0.13), Metro (0.12; 0.10–0.14), and Mesuji (0.13; 0.11–0.16). Temporal variation was also significant (p<0.001), with December showing the largest reduction relative to January (CR 0.68; 95% CI 0.58–0.78).
Conclusions: TB treatment initiation in Lampung showed marked geographic and temporal heterogeneity. These findings represent variation in recorded treatment volumes rather than treatment coverage. Linking surveillance records with diagnostic denominators, population data, and multi-year observations could strengthen subnational monitoring and guide locally targeted TB control strategies.
This study identifies the malaria prevalence and estimate its association with climatic situations, including temperature, rainfall, and humidity, in the three-year post-flood period (2023-2025) in District Sohbatpur. The study was done using a retrospective observational cohort study based on secondary data (DHIS-2 system of District Headquarter Hospital Sohbatpur) and primary data (structured questionnaire). Meteorological information was available in online climatic databases. To assess patterns and correlations between the malaria incidence and climatic variables, descriptive statistics and regression analysis were used. A total of 242,799 people were tested with 66,893 confirmed cases. Test Positivity Rate (TPR) fell in 2023 to 40.55% in 2025 which shows a decrease in the total malaria burden. Nevertheless, the rate of Plasmodium falciparum rose to 63.9% as compared to 47.2% with a decline in Plasmodium vivax and mixed infections. The male percentage was 50.40% indicating occupational exposure. There was a high seasonality in malaria incidence, which was highest during the times of increased temperature and rainfall. The highest increase in transmission occurred at temperatures above 20-25°C with moderate humidity contributing to the survival of the vectors. Regression analysis showed that the temperature, rainfall, and malaria incidence were meaningfully associated.The prevalence of malaria decreased overall, but the proportion of the more serious P. falciparum is increasing, reflecting a changing epidemiological trend. Climatic conditions, and especially temperature and rainfall are very critical in transmission. The concept of climate-informed surveillance and intervention strategies is key to effective malaria control in susceptible post-disaster environments such as Sohbatpur.
An examination of 104 patients with migraine aged 16 to 45 years was carried out duplex scanning (DS) and magnetic resonance methods tomography (MRI). The composition was evaluated substances of the brain and cerebral hemodynamics in patients with migraine without aura (59 patients) and with migraine with aura (45 patients).Structural changes white substances of the brain in the form of hyperintense on T2VI and predominantly isointense on T1VI focus there were 3 to 12 mm revealed in 28.8% of patients with migraine without aura and 53.3% of patients with migraine with aura. The foci were localized mainly in the white matter of the superior lobes (35.2% of patients with migraine without aura and 41.6% of patients with migraine with aura). According to Doppler studies in patients with migraine without aura prevailed vasospastic reactions in the middle brain arteries With migraine with aura more often was noted difficult perfusion in the middle cerebral and vertebral artery.
Eclampsia remains a major contributor to maternal and perinatal mortality, particularly in resource-limited settings where disparities in healthcare access and quality persist. This review examines the current evidence on the pathophysiology, global burden, diagnostic challenges, and management strategies of eclampsia, with a focus on low- and middle-income countries. A narrative review methodology was employed, synthesizing findings from existing literature and clinical reports.
The findings highlight significant barriers to effective management, including limited diagnostic infrastructure, inconsistent availability and use of magnesium sulfate, delayed patient presentation, and severe healthcare workforce shortages. These systemic challenges contribute to high case fatality rates and poor maternal outcomes. Additionally, sociocultural factors, inadequate health literacy, and weak health systems further exacerbate delays in diagnosis and treatment.
The study emphasizes the need for context-specific interventions, including community-based surveillance, task-sharing, mHealth innovations, and the implementation of standardized care protocols. Strengthening healthcare systems and improving access to timely, evidence-based interventions are critical to reducing preventable deaths associated with eclampsia in resource-constrained environments.
Taif is situated at approximately 1,800 m above sea level, below the conventional threshold for high altitude but sufficiently elevated to justify investigation of oxygen-sensitive phenotypes. Its community-genetics profile is also shaped by consanguinity, family-specific founder variants, and a substantial burden of autosomal-recessive disease. This critical narrative review separates three related questions: the hereditary-disorder spectrum relevant to Saudi and Arab populations, the molecular biology of adaptation to severe high-altitude hypoxia, and the currently untested possibility that moderate-altitude residence modifies disease expression in Taif. Evidence from Saudi genomic programs supports family-based exome or genome sequencing, homozygosity mapping, segregation analysis, and population-specific variant interpretation. Priority clinical groups include neurodevelopmental disorders, inherited retinal disease, hemoglobinopathies, inborn errors of metabolism, mitochondrial disease, and congenital anomalies. Studies of Tibetan, Andean, and Ethiopian populations establish the importance of hypoxia-inducible factor signaling, particularly EPAS1 and EGLN1, but these findings cannot be transferred directly to Taif. Direct local human genomic evidence remains sparse, and the available Taif study of oxidative stress used an animal model rather than a resident population. We propose a staged community genomics program integrating a regional registry, standardized phenotyping, family-centered sequencing, ancestry-aware analyses, a lower-altitude Saudi comparison group, and clinically governed return of results. This approach could improve diagnosis, carrier screening, counseling, and precision prevention while testing whether moderate altitude modifies hematologic, cardiopulmonary, or metabolic phenotypes.
